Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news


EFSA health claim opinion

Get inulin! Northern European giants win EFSA claim for non-digestible carbs and glycaemia

By Shane Starling+

Last updated on 30-Jan-2014 at 16:33 GMT2014-01-30T16:33:30Z

Inulin players:
Inulin players: "[The opinion]...represents new opportunities for the food industry to meet consumers’ demand for more low glycaemic and tasty products.”

The three giants of chicory-derived inulin and fructo-oligosaccharides (FOS) supply have won a significant European Food Safety Authority (EFSA) health claim approval linking non-digestible carbohydrates and improved blood glucose response.

Similar claims had previously been rejected by EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) over characterisation and other issues, but new studies swung the panel's verdict 180 degrees.

The dossier submitted by Beneo (Germany and Belgium), Sensus (the Netherlands) and Cosucra-Groupe Warcoing (Belgium) featured three human intervention studies and three human mechanistic studies which convinced the NDA, “that the consumption of foods/drinks in which non-digestible carbohydrates replaced sugars induced lower post-prandial glycaemic and insulinaemic responses than sugar-containing foods/drinks.”

Some of the data showed a reduced post prandial sugar response when only 20% of sugars were replaced, although the NDA conditions of use stipulate 30% replacement to carry the claim.

The ability of foods to affect blood glucose levels is commonly measured by the Glycaemic Index (GI), with short chain, digestible carbohydrates like sugar having the highest score while beans and grains reside at the low end of the scale.

FOS, non-starch polysaccharides, resistant oligosaccharides and resistant starch will be able to bear the claim under article 13.5 of the European Union nutrition and health claims regulation (NHCR) if it is mandated by the European Commission and EU member states in the coming months. Article 13.5 of the NHCR deals with claims relating to emerging science or those based on proprietary science that is granted five years of confidentiality under the regulation.

“The dossier submitted to EFSA was based on several studies including newly developed science, and shows that oligofructose has a significant part to play in the area of glycaemic control,” the three companies said in a joint statement.

EFSA's approved claim wording

“Consumption of foods/drinks containing non-digestible carbohydrates instead of sugars induces a lower blood glucose rise after meals compared to sugar-containing foods/drinks”.

“The research has provided additional physiological evidence why oligofructose is a very suitable sugar replacer and therefore represents new opportunities for the food industry to meet consumers’ demand for more low glycaemic and tasty products.”

The three firms added: “With increasing challenges placed on society by diet related diseases such as obesity, overweight, impaired glucose tolerance and diabetes, there is increased emphasis on food and drink producers supporting the development of new, lower glycaemic response products.”

The NDA opinion can be found here .

Inulin also functions as a prebiotic but such claims have not yet won EFSA approval.

Correction: This article initially stated that Sensus was Belgian. Sensus is Dutch.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars